CME Group Inc. Files 8-K Report

TL;DR

CME filed an 8-K, likely routine updates. Nothing major disclosed yet.

AI Summary

On December 5, 2024, CME Group Inc. filed an 8-K report. The filing primarily serves as a notification of other events and includes financial statements and exhibits. No specific material events or transactions are detailed in the provided excerpt, suggesting it may be a routine filing or related to ongoing disclosures.

Why It Matters

This filing indicates CME Group Inc. is providing updated information to the SEC, which could include routine disclosures or updates on ongoing business matters.

Risk Assessment

Risk Level: low — The provided excerpt of the 8-K filing does not contain specific material events or financial details that would indicate a high-risk situation.

Key Players & Entities

• CME GROUP INC. (company) — Registrant
• 0001156375 (company) — Central Index Key
• 20 South Wacker Drive Chicago, Illinois 60606 (company) — Principal executive offices address
• December 5, 2024 (date) — Date of earliest event reported

FAQ

From the Filing

0001193125-24-271111.txt : 20241205 0001193125-24-271111.hdr.sgml : 20241205 20241205074202 ACCESSION NUMBER: 0001193125-24-271111 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20241205 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241205 DATE AS OF CHANGE: 20241205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CME GROUP INC. CENTRAL INDEX KEY: 0001156375 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200] ORGANIZATION NAME: 02 Finance IRS NUMBER: 364459170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31553 FILM NUMBER: 241527847 BUSINESS ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 3129301000 MAIL ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: CHICAGO MERCANTILE EXCHANGE HOLDINGS INC DATE OF NAME CHANGE: 20010802 8-K 1 d888723d8k.htm 8-K 8-K false 0001156375 0001156375 2024-12-05 2024-12-05     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2024     CME GROUP INC. (Exact name of registrant as specified in its charter)       Delaware   001-31553   36-4459170 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   20 South Wacker Drive Chicago , Illinois   60606 (Address of principal executive offices)   (Zip Code) Registrant’s telephone number, including area code: (312) 930-1000 N/A (Former name or former address, if changed since last report.)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Class A Common Stock   CME   The Nasdaq Stock Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 7.01 Regulation FD Disclosure. On December 5, 2024, CME Group Inc. (“CME Group”) issued a press release regarding the share repurchase program described in Item 8.01 of this report. A copy of the press release is furnished with this report as Exhibit 99.1 and is incorporated herein by reference. The information furnished under Item 7.01 of this report, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),